IMC Chicago’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.37M Buy
643,030
+150,132
+30% +$510K ﹤0.01% 2529
2026
Q1
$868K Sell
492,898
-150,066
-23% -$325K ﹤0.01% 3422
2025
Q4
$1.51M Sell
642,964
-216,949
-25% -$593K ﹤0.01% 2642
2025
Q3
$2.63M Buy
859,913
+375,272
+77% +$1.07M ﹤0.01% 2043
2025
Q2
$1.35M Buy
484,641
+292,090
+152% +$960K ﹤0.01% 2279
2025
Q1
$691K Buy
+192,551
New +$773K ﹤0.01% 2487
2022
Q4
Sell
-143,185
Closed -$191K 1264
2022
Q3
$243K Buy
143,185
+18,195
+15% +$47.7K ﹤0.01% 1172
2022
Q2
$267K Buy
+124,990
New +$332K ﹤0.01% 1033
2021
Q4
Sell
-152,548
Closed -$936K 1190
2021
Q3
$1.13M Buy
152,548
+42,592
+39% +$364K ﹤0.01% 971
2021
Q2
$1.47M Buy
+109,956
New +$1.08M ﹤0.01% 832

Other funds holding CLOV

IMC Chicago's CLOV Position: Q2 2026 in Review

IMC Chicago increased its Clover Health Investments (CLOV) stake by 30% in Q2 2026, buying an estimated $510K and bringing the position to 643,030 shares worth $3.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2529.

IMC Chicago first reported a position in CLOV in Q2 2021 and has held it in 10 quarters since. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • IMC Chicago held 643,030 shares of Clover Health Investments worth $3.37M as of Q2 2026.
  • IMC Chicago bought 150,132 Clover Health Investments shares in Q2 2026, an estimated $510K.
  • Clover Health Investments made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #2529 holding.
  • IMC Chicago first reported a position in Clover Health Investments in Q2 2021 and has held it in 10 quarters since.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.